Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573) (VAng-Lsx0056)

Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Datasheet

Inquiry

Specifications

Source

Human

Target

Coronavirus

Type

Viral Antigens

Applications

ELISA, WB, SDS-PAGE, Immunogen, etc.

Formulation

25mM Tris-HCl, 0.4 % sarcosyl, 0, 25 % Triton –100 and 50 % glycerol.

Purity

> 95 % pure by 10 % SDS-PAGE.

Storage

Store at 2 °C to 8 °C short term, -20 °C long term.

Antigen Information

Introduction

The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS. Samples of the virus are being held in laboratories in New York, San Francisco, Manila, Hong Kong, and Toronto. protein E is a kinesin-like motor protein that accumulates in the G2 phase of the cell cycle. Unlike other centromere-associated proteins, it is not present during interphase and first appears at the centromere region of chromosomes during prometaphase. CENPE is proposed to be one of the motors responsible for mammalian chromosome movement and/or spindle elongation.

Alternative Names

SARS Spike Protein; SARS spike glycoprotein; SARS Spike Protein (Middle Region); SARS (Severe Acute Respiratory Syndrome) Spike protein, Middle region; Group IV; Nidovirales; Coronaviridae; Coronavirus; SARS coronavirus; SARS; Severe acute respiratory syn